[10-Q] AMERISAFE, Inc. Quarterly Earnings Report
Intellia Therapeutics, Inc. (NTLA) – Form 4 insider filing
EVP & CFO Edward J. Dulac III executed an automatic, non-volitional sale of 7,462 common shares on 23 Jul 2025 at $14.02 per share. The disposition was a mandatory “sell-to-cover” to satisfy federal and state tax-withholding obligations triggered by the vesting of RSUs on 22 Jul 2025.
Post-transaction, Dulac directly owns 106,062 NTLA shares; no indirect holdings or derivative security changes were reported. No options were exercised or granted, and the filing does not disclose any additional share sales or purchases.
The event does not materially alter management’s economic exposure to the company and should be viewed as administrative rather than discretionary trading activity.
Intellia Therapeutics, Inc. (NTLA) – Comunicazione interna Form 4
Edward J. Dulac III, EVP e CFO, ha effettuato una vendita automatica e non volontaria di 7.462 azioni ordinarie il 23 luglio 2025 al prezzo di $14,02 per azione. La vendita è stata una cessione obbligatoria “sell-to-cover” per adempiere agli obblighi di ritenuta fiscale federale e statale scaturiti dal maturare delle RSU il 22 luglio 2025.
Dopo la transazione, Dulac detiene direttamente 106.062 azioni NTLA; non sono stati segnalati cambiamenti in partecipazioni indirette o strumenti derivati. Non sono state esercitate o concesse opzioni, e la comunicazione non riporta altre vendite o acquisti di azioni.
L’evento non modifica sostanzialmente l’esposizione economica del management verso la società e va considerato come un’attività amministrativa più che un’operazione discrezionale di trading.
Intellia Therapeutics, Inc. (NTLA) – Presentación interna Formulario 4
Edward J. Dulac III, EVP y CFO, realizó una venta automática y no voluntaria de 7,462 acciones ordinarias el 23 de julio de 2025 a $14.02 por acción. La disposición fue una venta obligatoria “sell-to-cover” para cumplir con las obligaciones de retención fiscal federales y estatales generadas por la consolidación de RSU el 22 de julio de 2025.
Después de la transacción, Dulac posee directamente 106,062 acciones NTLA; no se reportaron cambios en participaciones indirectas ni en valores derivados. No se ejercieron ni otorgaron opciones, y la presentación no revela otras ventas o compras de acciones.
Este evento no altera materialmente la exposición económica de la administración a la compañía y debe considerarse una actividad administrativa más que una operación discrecional de trading.
Intellia Therapeutics, Inc. (NTLA) – 내부자 거래 신고서(Form 4)
부사장 겸 최고재무책임자(Edward J. Dulac III)가 2025년 7월 23일에 7,462주의 보통주를 주당 14.02달러에 자동으로 비자발적 매도하였습니다. 이번 매도는 2025년 7월 22일 RSU가 확정됨에 따라 발생한 연방 및 주 세금 원천징수 의무를 충족하기 위한 의무적 'sell-to-cover' 처분이었습니다.
거래 후 Dulac는 직접 106,062주의 NTLA 주식을 보유하고 있으며, 간접 보유나 파생상품 변동은 보고되지 않았습니다. 옵션의 행사나 부여는 없었으며, 추가적인 주식 매매 내역도 공개되지 않았습니다.
이번 사건은 경영진의 회사에 대한 경제적 노출에 실질적인 변화를 주지 않으며, 자발적 거래보다는 행정적 조치로 봐야 합니다.
Intellia Therapeutics, Inc. (NTLA) – Déclaration d’initié Formulaire 4
Edward J. Dulac III, EVP et CFO, a effectué une vente automatique et non volontaire de 7 462 actions ordinaires le 23 juillet 2025 au prix de 14,02 $ par action. Cette cession était une obligation « sell-to-cover » destinée à satisfaire les retenues fiscales fédérales et étatiques déclenchées par la consolidation des RSU le 22 juillet 2025.
Après la transaction, Dulac détient directement 106 062 actions NTLA ; aucun changement dans les participations indirectes ou les titres dérivés n’a été signalé. Aucune option n’a été exercée ou attribuée, et la déclaration ne mentionne aucune autre vente ou achat d’actions.
L’événement ne modifie pas de manière significative l’exposition économique de la direction à la société et doit être considéré comme une opération administrative plutôt que comme une transaction discrétionnaire.
Intellia Therapeutics, Inc. (NTLA) – Insider-Meldung Form 4
EVP & CFO Edward J. Dulac III führte am 23. Juli 2025 einen automatischen, nicht freiwilligen Verkauf von 7.462 Stammaktien zum Preis von 14,02 $ pro Aktie durch. Die Veräußerung war ein verpflichtendes "sell-to-cover", um bundesstaatliche und staatliche Steuerabzugsverpflichtungen zu erfüllen, die durch die Vesting von RSUs am 22. Juli 2025 ausgelöst wurden.
Nach der Transaktion besitzt Dulac direkt 106.062 NTLA-Aktien; keine indirekten Beteiligungen oder Änderungen bei derivativen Wertpapieren wurden gemeldet. Es wurden keine Optionen ausgeübt oder gewährt, und die Meldung enthält keine weiteren Aktienverkäufe oder -käufe.
Das Ereignis verändert die wirtschaftliche Beteiligung des Managements am Unternehmen nicht wesentlich und sollte als administrative und nicht als diskretionäre Handelsaktivität betrachtet werden.
- Executive retains 106,062 shares, indicating continued alignment with shareholder interests.
- Transaction was pre-programmed and tax-driven, reducing concerns about opportunistic insider selling.
- Even administrative insider sales can create superficial bearish headlines that may pressure short-term sentiment.
Insights
TL;DR: Routine sell-to-cover, neutral signal.
The CFO’s 7,462-share sale—only ~7% of his 106k-share stake—was required to cover taxes on vested RSUs, a common practice that avoids out-of-pocket tax payments. Because the shares were disposed automatically and promptly disclosed, the transaction offers little insight into management’s outlook on NTLA fundamentals. Insider ownership remains significant, supporting alignment with shareholders. I regard the filing as operationally neutral with no valuation impact.
TL;DR: Compliant disclosure, immaterial governance impact.
The form demonstrates timely Section 16 compliance, detailing a tax-driven sale under Rule 10b5-1-like mechanics. Such sell-to-cover transactions are typically pre-approved and avoid potential trading-window issues. Retention of over 100k shares preserves meaningful ‘skin in the game,’ and no red flags emerge regarding unusual trading patterns. Governance impact is minimal; investors should focus on broader performance catalysts rather than this single administrative filing.
Intellia Therapeutics, Inc. (NTLA) – Comunicazione interna Form 4
Edward J. Dulac III, EVP e CFO, ha effettuato una vendita automatica e non volontaria di 7.462 azioni ordinarie il 23 luglio 2025 al prezzo di $14,02 per azione. La vendita è stata una cessione obbligatoria “sell-to-cover” per adempiere agli obblighi di ritenuta fiscale federale e statale scaturiti dal maturare delle RSU il 22 luglio 2025.
Dopo la transazione, Dulac detiene direttamente 106.062 azioni NTLA; non sono stati segnalati cambiamenti in partecipazioni indirette o strumenti derivati. Non sono state esercitate o concesse opzioni, e la comunicazione non riporta altre vendite o acquisti di azioni.
L’evento non modifica sostanzialmente l’esposizione economica del management verso la società e va considerato come un’attività amministrativa più che un’operazione discrezionale di trading.
Intellia Therapeutics, Inc. (NTLA) – Presentación interna Formulario 4
Edward J. Dulac III, EVP y CFO, realizó una venta automática y no voluntaria de 7,462 acciones ordinarias el 23 de julio de 2025 a $14.02 por acción. La disposición fue una venta obligatoria “sell-to-cover” para cumplir con las obligaciones de retención fiscal federales y estatales generadas por la consolidación de RSU el 22 de julio de 2025.
Después de la transacción, Dulac posee directamente 106,062 acciones NTLA; no se reportaron cambios en participaciones indirectas ni en valores derivados. No se ejercieron ni otorgaron opciones, y la presentación no revela otras ventas o compras de acciones.
Este evento no altera materialmente la exposición económica de la administración a la compañía y debe considerarse una actividad administrativa más que una operación discrecional de trading.
Intellia Therapeutics, Inc. (NTLA) – 내부자 거래 신고서(Form 4)
부사장 겸 최고재무책임자(Edward J. Dulac III)가 2025년 7월 23일에 7,462주의 보통주를 주당 14.02달러에 자동으로 비자발적 매도하였습니다. 이번 매도는 2025년 7월 22일 RSU가 확정됨에 따라 발생한 연방 및 주 세금 원천징수 의무를 충족하기 위한 의무적 'sell-to-cover' 처분이었습니다.
거래 후 Dulac는 직접 106,062주의 NTLA 주식을 보유하고 있으며, 간접 보유나 파생상품 변동은 보고되지 않았습니다. 옵션의 행사나 부여는 없었으며, 추가적인 주식 매매 내역도 공개되지 않았습니다.
이번 사건은 경영진의 회사에 대한 경제적 노출에 실질적인 변화를 주지 않으며, 자발적 거래보다는 행정적 조치로 봐야 합니다.
Intellia Therapeutics, Inc. (NTLA) – Déclaration d’initié Formulaire 4
Edward J. Dulac III, EVP et CFO, a effectué une vente automatique et non volontaire de 7 462 actions ordinaires le 23 juillet 2025 au prix de 14,02 $ par action. Cette cession était une obligation « sell-to-cover » destinée à satisfaire les retenues fiscales fédérales et étatiques déclenchées par la consolidation des RSU le 22 juillet 2025.
Après la transaction, Dulac détient directement 106 062 actions NTLA ; aucun changement dans les participations indirectes ou les titres dérivés n’a été signalé. Aucune option n’a été exercée ou attribuée, et la déclaration ne mentionne aucune autre vente ou achat d’actions.
L’événement ne modifie pas de manière significative l’exposition économique de la direction à la société et doit être considéré comme une opération administrative plutôt que comme une transaction discrétionnaire.
Intellia Therapeutics, Inc. (NTLA) – Insider-Meldung Form 4
EVP & CFO Edward J. Dulac III führte am 23. Juli 2025 einen automatischen, nicht freiwilligen Verkauf von 7.462 Stammaktien zum Preis von 14,02 $ pro Aktie durch. Die Veräußerung war ein verpflichtendes "sell-to-cover", um bundesstaatliche und staatliche Steuerabzugsverpflichtungen zu erfüllen, die durch die Vesting von RSUs am 22. Juli 2025 ausgelöst wurden.
Nach der Transaktion besitzt Dulac direkt 106.062 NTLA-Aktien; keine indirekten Beteiligungen oder Änderungen bei derivativen Wertpapieren wurden gemeldet. Es wurden keine Optionen ausgeübt oder gewährt, und die Meldung enthält keine weiteren Aktienverkäufe oder -käufe.
Das Ereignis verändert die wirtschaftliche Beteiligung des Managements am Unternehmen nicht wesentlich und sollte als administrative und nicht als diskretionäre Handelsaktivität betrachtet werden.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE QUARTERLY PERIOD ENDED
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE TRANSITION PERIOD FROM TO
Commission File Number:
(Exact Name of Registrant as Specified in Its Charter)
|
||
(State of Incorporation) |
|
(I.R.S. Employer Identification Number) |
|
|
|
|
||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
☒ |
|
Accelerated filer |
|
☐ |
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
|
|
|
|
|
Emerging growth company |
|
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of July 18, 2025, there were
TABLE OF CONTENTS
|
|
|
Page |
|
|
|
No. |
|
|
|
|
FORWARD-LOOKING STATEMENTS |
3 |
||
|
|
|
|
PART I - FINANCIAL INFORMATION |
|
||
|
|
|
|
Item 1 |
|
Financial Statements |
4 |
|
|
|
|
Item 2 |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
23 |
|
|
|
|
Item 3 |
|
Quantitative and Qualitative Disclosures About Market Risk |
29 |
|
|
|
|
Item 4 |
|
Controls and Procedures |
29 |
|
|
|
|
PART II - OTHER INFORMATION |
|
||
|
|
|
|
Item 2 |
|
Unregistered Sales of Equity Securities and Use of Proceeds |
30 |
|
|
|
|
Item 5 |
|
Other Information |
30 |
|
|
|
|
Item 6 |
|
Exhibits |
31 |
2
FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934. Forward-looking statements are all statements other than statements of historical facts. You should not place undue reliance on these statements. These forward-looking statements include statements that reflect the current views of our senior management with respect to our financial performance and future events with respect to our business and the insurance industry in general. Statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “could,” “to be,” “anticipate” and similar statements of a future or forward-looking nature identify forward-looking statements.
Forward-looking statements address matters that involve risks and uncertainties. Forward-looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause our actual results to differ materially from those expressed or implied in these statements. We believe that these factors include, but are not limited to, the following:
The foregoing factors should not be construed as exhaustive and should be read together with the other risks described in this report and other factors described under the caption “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024 and as may be further amended by subsequent filings with the SEC. If one or more events related to these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may differ materially from what we anticipate. Investors are cautioned that many of the assumptions upon which these forward-looking statements are based are likely to change after the date the forward-looking statements are made. We undertake no obligation to update or revise any forward-looking statements, which speak only as of the date made, notwithstanding any changes in our assumptions, actual experience or other changes that arise after the date of this report.
3
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
AMERISAFE, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
||
|
|
(unaudited) |
|
|
|
|
||
Assets |
|
|
|
|
|
|
||
Investments: |
|
|
|
|
|
|
||
Fixed maturity securities—held-to-maturity, at amortized cost net of allowance |
|
$ |
|
|
$ |
|
||
Fixed maturity securities—available-for-sale, at fair value |
|
|
|
|
|
|
||
Equity securities, at fair value |
|
|
|
|
|
|
||
Short-term investments |
|
|
|
|
|
|
||
Total investments |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
|
|
|
|
|
||
Amounts recoverable from reinsurers |
|
|
|
|
|
|
||
Premiums receivable |
|
|
|
|
|
|
||
Deferred income taxes |
|
|
|
|
|
|
||
Accrued interest receivable |
|
|
|
|
|
|
||
Property and equipment, net |
|
|
|
|
|
|
||
Deferred policy acquisition costs |
|
|
|
|
|
|
||
Federal income tax recoverable |
|
|
|
|
|
|
||
Other assets |
|
|
|
|
|
|
||
Total assets |
|
$ |
|
|
$ |
|
||
Liabilities and shareholders’ equity |
|
|
|
|
|
|
||
Liabilities: |
|
|
|
|
|
|
||
Reserves for loss and loss adjustment expenses |
|
$ |
|
|
$ |
|
||
Unearned premiums |
|
|
|
|
|
|
||
Amounts held for others |
|
|
|
|
|
|
||
Policyholder deposits |
|
|
|
|
|
|
||
Insurance-related assessments |
|
|
|
|
|
|
||
Accounts payable and other liabilities |
|
|
|
|
|
|
||
Payable for investments purchased |
|
|
|
|
|
|
||
Total liabilities |
|
|
|
|
|
|
||
Shareholders’ equity: |
|
|
|
|
|
|
||
Common stock: voting—$ |
|
|
|
|
|
|
||
Additional paid-in capital |
|
|
|
|
|
|
||
Treasury stock, at cost ( |
|
|
( |
) |
|
|
( |
) |
Accumulated earnings |
|
|
|
|
|
|
||
Accumulated other comprehensive loss, net |
|
|
( |
) |
|
|
( |
) |
Total shareholders’ equity |
|
|
|
|
|
|
||
Total liabilities and shareholders’ equity |
|
$ |
|
|
$ |
|
See accompanying notes.
4
AMERISAFE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except share and per share data)
(unaudited)
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Gross premiums written |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Ceded premiums written |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Net premiums written |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Net premiums earned |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Net investment income |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net realized gains (losses) on investments |
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
||
Net unrealized gains (losses) on equity securities |
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
|
||
Fee and other income (losses) |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|||
Total revenues |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Loss and loss adjustment expenses incurred |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Underwriting and certain other operating costs |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Commissions |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Salaries and benefits |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Policyholder dividends |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Provision for investment related credit loss benefit |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
Total expenses |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Income before income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Income tax expense |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Diluted |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Shares used in computing earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash dividends declared per common share |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
See accompanying notes.
5
AMERISAFE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
(unaudited)
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
Net income |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Other comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Unrealized gain (loss) on debt securities, net of tax |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
Comprehensive income |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
See accompanying notes.
6
AMERISAFE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
Three Months Ended June 30, 2025 and 2024
(in thousands, except share data)
(unaudited)
|
|
Common Stock |
|
|
Additional |
|
|
Treasury Stock |
|
|
Accumulated |
|
|
Accumulated |
|
|
|
|
||||||||||||||
|
|
Shares |
|
|
Amounts |
|
|
Capital |
|
|
Shares |
|
|
Amounts |
|
|
Earnings |
|
|
Loss |
|
|
Total |
|
||||||||
Balance at March 31, 2025 |
|
|
|
|
$ |
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Other comprehensive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in unrealized |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Common stock issued |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||||
Purchase of treasury stock |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Share-based compensation |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Dividends to shareholders |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Balance at June 30, 2025 |
|
|
|
|
$ |
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Common Stock |
|
|
Additional |
|
|
Treasury Stock |
|
|
Accumulated |
|
|
Accumulated |
|
|
|
|
||||||||||||||
|
|
Shares |
|
|
Amounts |
|
|
Capital |
|
|
Shares |
|
|
Amounts |
|
|
Earnings |
|
|
Loss |
|
|
Total |
|
||||||||
Balance at March 31, 2024 |
|
|
|
|
$ |
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Other comprehensive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in unrealized |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Common stock issued |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Purchase of treasury stock |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Share-based compensation |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Dividends to shareholders |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Balance at June 30, 2024 |
|
|
|
|
$ |
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
See accompanying notes.
7
AMERISAFE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
Six Months Ended June 30, 2025 and 2024
(in thousands, except share data)
(unaudited)
|
|
Common Stock |
|
|
Additional |
|
|
Treasury Stock |
|
|
Accumulated |
|
|
Accumulated |
|
|
|
|
||||||||||||||
|
|
Shares |
|
|
Amounts |
|
|
Capital |
|
|
Shares |
|
|
Amounts |
|
|
Earnings |
|
|
Loss |
|
|
Total |
|
||||||||
Balance at December 31, 2024 |
|
|
|
|
$ |
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Other comprehensive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in unrealized |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
||
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Common stock issued |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||||
Purchase of treasury stock |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Share-based compensation |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Dividends to shareholders |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Balance at June 30, 2025 |
|
|
|
|
$ |
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Common Stock |
|
|
Additional |
|
|
Treasury Stock |
|
|
Accumulated |
|
|
Accumulated |
|
|
|
|
||||||||||||||
|
|
Shares |
|
|
Amounts |
|
|
Capital |
|
|
Shares |
|
|
Amounts |
|
|
Earnings |
|
|
Loss |
|
|
Total |
|
||||||||
Balance at December 31, 2023 |
|
|
|
|
$ |
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Other comprehensive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in unrealized |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Common stock issued |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Purchase of treasury stock |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Share-based compensation |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Dividends to shareholders |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
( |
) |
|
|
— |
|
|
|
( |
) |
Balance at June 30, 2024 |
|
|
|
|
$ |
|
|
$ |
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
See accompanying notes.
8
AMERISAFE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
|
|
Six Months Ended June 30, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Operating activities |
|
|
|
|
|
|
||
Net income |
|
$ |
|
|
$ |
|
||
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
||
Depreciation |
|
|
|
|
|
|
||
Net amortization of investments |
|
|
|
|
|
|
||
Change in investment related allowance for credit losses |
|
|
( |
) |
|
|
( |
) |
Deferred income taxes |
|
|
( |
) |
|
|
( |
) |
Net realized (gains) losses on investments |
|
|
( |
) |
|
|
|
|
Net unrealized (gains) losses on equity securities |
|
|
|
|
|
( |
) |
|
Net realized losses on disposal of assets |
|
|
|
|
|
|
||
Share-based compensation |
|
|
|
|
|
|
||
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Premiums receivable, net |
|
|
( |
) |
|
|
( |
) |
Accrued interest receivable |
|
|
( |
) |
|
|
|
|
Deferred policy acquisition costs |
|
|
( |
) |
|
|
( |
) |
Other assets |
|
|
|
|
|
( |
) |
|
Reserves for loss and loss adjustment expenses |
|
|
( |
) |
|
|
( |
) |
Unearned premiums |
|
|
|
|
|
|
||
Reinsurance balances |
|
|
|
|
|
|
||
Amounts held for others and policyholder deposits |
|
|
( |
) |
|
|
( |
) |
Federal income taxes recoverable |
|
|
( |
) |
|
|
|
|
Accounts payable and other liabilities |
|
|
|
|
|
|
||
Net cash provided by (used in) operating activities |
|
|
( |
) |
|
|
|
|
Investing activities |
|
|
|
|
|
|
||
Purchases of investments held-to-maturity |
|
|
|
|
|
( |
) |
|
Purchases of investments available-for-sale |
|
|
( |
) |
|
|
( |
) |
Purchases of equity securities |
|
|
( |
) |
|
|
— |
|
Purchases of short-term investments |
|
|
( |
) |
|
|
( |
) |
Proceeds from maturities of investments held-to-maturity |
|
|
|
|
|
|
||
Proceeds from sales and maturities of investments available-for-sale |
|
|
|
|
|
|
||
Proceeds from sales of equity securities |
|
|
|
|
|
|
||
Purchases of property and equipment |
|
|
( |
) |
|
|
( |
) |
Net cash provided by investing activities |
|
|
|
|
|
|
||
Financing activities |
|
|
|
|
|
|
||
Finance lease purchases |
|
|
( |
) |
|
|
( |
) |
Share-based compensation related tax withholding |
|
|
( |
) |
|
|
( |
) |
Purchase of treasury stock |
|
|
( |
) |
|
|
( |
) |
Dividends to shareholders |
|
|
( |
) |
|
|
( |
) |
Net cash used in financing activities |
|
|
( |
) |
|
|
( |
) |
Change in cash and cash equivalents |
|
|
|
|
|
( |
) |
|
Cash and cash equivalents at beginning of period |
|
|
|
|
|
|
||
Cash and cash equivalents at end of period |
|
$ |
|
|
$ |
|
See accompanying notes.
9
AMERISAFE, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Note 1. Basis of Presentation
AMERISAFE, Inc. (the Company) is an insurance holding company incorporated in the state of Texas. The accompanying unaudited consolidated financial statements include the accounts of the Company and its subsidiaries: American Interstate Insurance Company (AIIC) and its insurance subsidiaries, Silver Oak Casualty, Inc. (SOCI) and American Interstate Insurance Company of Texas (AIICTX), Amerisafe Risk Services, Inc. (RISK) and Amerisafe General Agency, Inc. (AGAI). AIIC and SOCI are property and casualty insurance companies organized under the laws of the state of Nebraska. AIICTX is a property and casualty insurance company organized under the laws of the state of Texas. RISK, a wholly owned subsidiary of the Company, is a claims and safety service company currently servicing only affiliated insurance companies. AGAI, a wholly owned subsidiary of the Company, is a general agent for the Company. AGAI sells insurance, which is underwritten by AIIC, SOCI and AIICTX, as well as by nonaffiliated insurance carriers.
The terms “AMERISAFE,” the “Company,” “we,” “us” or “our” refer to AMERISAFE, Inc. and its consolidated subsidiaries, as the context requires.
The Company provides workers’ compensation insurance for small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. Assets and revenues of AIIC and its subsidiaries represent at least
In the opinion of management of the Company, the accompanying unaudited consolidated financial statements contain all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, the results of operations and cash flows for the periods presented. The unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q under the Securities Exchange Act of 1934, as amended (the Exchange Act), and therefore do not include all information and footnotes to be in conformity with accounting principles generally accepted in the United States (GAAP). The results for the interim periods are not necessarily indicative of the results of operations that may be expected for the year. The unaudited consolidated financial statements contained herein should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2024.
The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of our assets, liabilities, revenues and expenses and related disclosures. Some of the estimates result from judgments that can be subjective and complex and, consequently, actual results in future periods might differ from these estimates.
Adopted Accounting Guidance
The Company has not adopted any new accounting guidance in 2025.
Prospective Accounting Guidance
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures, that requires expanded income tax disclosures, including the disaggregation of existing disclosures related to the tax rate reconciliation and income taxes paid. The guidance is effective for our Annual Report on Form 10-K for the year ended December 31, 2025. Early adoption of the new standard is permitted; however, we have not elected to early adopt the standard. Prospective application is required, with retrospective application permitted. We have analyzed the impacts and will provide the required disclosures upon adoption.
In November 2024, the FASB issued Accounting Standards Update 2024-03, Expense Disaggregation Disclosures, which requires disclosure of specified information about certain costs and expenses in the notes to the financial statements. The guidance is effective for our Annual Report on Form 10-K for the year ended December 31, 2027, and interim reporting periods beginning in 2028. Early adoption of the new standard is permitted; however, we have not elected to early adopt the standard. Prospective application is required, with retrospective application permitted. We are evaluating the impact of this disclosure-only requirement.
Note 2. Restricted Stock, Restricted Stock Units, and Stock Options
As of June 30, 2025, the Company has
10
Incentive Plan. All grants made under the 2012 Incentive Plan will continue in effect, subject to the terms and conditions of the 2012 Incentive Plan. See Note 12 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024 for additional information regarding the Company’s incentive plans.
During the six months ended June 30, 2025, the Company issued
The Company had
Note 3. Earnings Per Share
The Company computes earnings per share (EPS) in accordance with FASB Accounting Standards Codification (ASC) Topic 260, Earnings Per Share. The Company has no participating unvested common shares which contain nonforfeitable rights to dividends and applies the treasury stock method in computing basic and diluted earnings per share.
Basic EPS is calculated by dividing net income by the weighted-average number of common shares outstanding during the period.
The diluted EPS calculation includes potential common shares assumed issued under the treasury stock method, which reflects the potential dilution that would occur if any restricted stock or RSUs vest.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
|
(in thousands, except share and per share amounts) |
|
|||||||||||||
Basic EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Basic weighted average common shares |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic earnings per common share |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Diluted EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Diluted weighted average common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted average common shares |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Restricted stock and RSUs |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted weighted average common shares |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted earnings per common share |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
11
Note 4. Investments
The amortized cost, allowance for credit losses, carrying amount, gross unrecognized gains and losses, and the fair value of those investments classified as held-to-maturity at June 30, 2025 are summarized as follows:
|
|
Amortized |
|
|
Allowance for Credit Losses |
|
|
Carrying |
|
|
Gross |
|
|
Gross |
|
|
Fair |
|
||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
States and political subdivisions |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||||
Corporate bonds |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
( |
) |
|
|
|
||||
U.S. agency-based mortgage-backed securities |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
||||
U.S. Treasury securities and obligations |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
||||
Asset-backed securities |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||||
Totals |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
The amortized cost, gross unrealized gains and losses, fair value, and the allowance for credit losses of those investments classified as available-for-sale at June 30, 2025 are summarized as follows:
|
|
Amortized |
|
|
Gross |
|
|
Gross |
|
|
Fair |
|
|
Allowance for |
|
|||||
|
|
(in thousands) |
|
|||||||||||||||||
States and political subdivisions |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
— |
|
|||
Corporate bonds |
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
— |
|
|||
U.S. agency-based mortgage-backed securities |
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
— |
|
||
U.S. Treasury securities and obligations |
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
— |
|
||
Totals |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
— |
|
The cost, gross unrealized gains and losses, and the fair value of equity securities at June 30, 2025 are summarized as follows:
|
|
Cost |
|
|
Gross |
|
|
Gross |
|
|
Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Equity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Domestic common stock - Exchange Traded Funds |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|||
Total equity securities |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
The amortized cost, allowance for credit losses, carrying amount, gross unrecognized gains and losses, and the fair value of those investments classified as held-to-maturity at December 31, 2024 are summarized as follows:
|
|
Amortized |
|
|
Allowance for Credit Losses |
|
|
Carrying |
|
|
Gross |
|
|
Gross |
|
|
Fair |
|
||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
States and political subdivisions |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
||||
Corporate bonds |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
( |
) |
|
|
|
||||
U.S. agency-based mortgage-backed securities |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
||||
U.S. Treasury securities and obligations |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
||||
Asset-backed securities |
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|||
Totals |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
12
The amortized cost, gross unrealized gains and losses, fair value, and the allowance for credit losses of those investments classified as available-for-sale at December 31, 2024 are summarized as follows:
|
|
Amortized |
|
|
Gross |
|
|
Gross |
|
|
Fair |
|
|
Allowance for |
|
|||||
|
|
(in thousands) |
|
|||||||||||||||||
States and political subdivisions |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
— |
|
|||
Corporate bonds |
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
— |
|
|||
U.S. agency-based mortgage-backed securities |
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
— |
|
||
U.S. Treasury securities and obligations |
|
|
|
|
|
— |
|
|
|
( |
) |
|
|
|
|
|
— |
|
||
Totals |
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
— |
|
The cost, gross unrealized gains and losses, and the fair value of equity securities at December 31, 2024 are summarized as follows:
|
|
Cost |
|
|
Gross |
|
|
Gross |
|
|
Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Equity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Domestic common stock - Exchange Traded Funds |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|||
Total equity securities |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
A summary of the carrying amounts and fair value of investments in fixed maturity securities classified as held-to-maturity, by contractual maturity, is as follows:
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
||||||||||
|
|
Carrying |
|
|
Fair |
|
|
Carrying |
|
|
Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Within one year |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
After one year through five years |
|
|
|
|
|
|
|
|
|
|
|
|
||||
After five years through ten years |
|
|
|
|
|
|
|
|
|
|
|
|
||||
After ten years |
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. agency-based mortgage-backed securities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Asset-backed securities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Totals |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
A summary of the amortized cost and fair value of investments in fixed maturity securities classified as available-for-sale, by contractual maturity, is as follows:
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
||||||||||
|
|
Amortized |
|
|
Fair |
|
|
Amortized |
|
|
Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Within one year |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
After one year through five years |
|
|
|
|
|
|
|
|
|
|
|
|
||||
After five years through ten years |
|
|
|
|
|
|
|
|
|
|
|
|
||||
After ten years |
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. agency-based mortgage-backed securities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Totals |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
13
The following table summarizes the fair value and gross unrealized losses on securities classified as available-for-sale, aggregated by major investment category and length of time that the individual securities have been in a continuous unrealized loss position as of June 30, 2025.
|
|
Less Than 12 Months |
|
|
12 Months or Greater |
|
|
Total |
|
|||||||||||||||
|
|
Fair Value of |
|
|
Gross |
|
|
Fair Value of |
|
|
Gross |
|
|
Fair Value of |
|
|
Gross |
|
||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
June 30, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Available-for-Sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
States and political subdivisions |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
Corporate bonds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
U.S. agency-based mortgage-backed securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
U.S. Treasury securities and obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total available-for-sale securities |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
At June 30, 2025, we held
The following table summarizes the fair value and gross unrealized losses on securities classified as available-for-sale, aggregated by major investment category and length of time that the individual securities have been in a continuous unrealized loss position as of December 31, 2024.
|
|
Less Than 12 Months |
|
|
12 Months or Greater |
|
|
Total |
|
|||||||||||||||
|
|
Fair Value of |
|
|
Gross |
|
|
Fair Value of |
|
|
Gross |
|
|
Fair Value of |
|
|
Gross |
|
||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
December 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Available-for-Sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
States and political subdivisions |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
Corporate bonds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
U.S. agency-based mortgage-backed securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
U.S. Treasury securities and obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total available-for-sale securities |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
The following table illustrates the changes in the allowance for credit losses by major security type of the investments classified as held-to-maturity for the quarter ended June 30, 2025.
|
|
States and |
|
|
Corporate |
|
|
U.S. Agency |
|
|
U.S. |
|
|
Asset-Backed |
|
|
Totals |
|
||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
Balance at March 31, 2025 |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
||||
Provision for credit loss benefit |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
( |
) |
|
Balance at June 30, 2025 |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
14
The following table illustrates the changes in the allowance for credit losses by major security type of the investments classified as held-to-maturity for the six months ended June 30, 2025.
|
|
States and |
|
|
Corporate |
|
|
U.S. Agency |
|
|
U.S. |
|
|
Asset-Backed |
|
|
Totals |
|
||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
Balance at December 31, 2024 |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
||||
Provision for credit loss benefit |
|
|
( |
) |
|
|
( |
) |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
( |
) |
|
Balance at June 30, 2025 |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
|
|
$ |
|
As of June 30, 2025, the Company has established an allowance for credit losses on
The Company has
The credit rating used for held-to-maturity fixed income securities is the rating for each security as published by Moody’s, Standard and Poor's, and Fitch to determine the probability of default. If there are two ratings, the lower rating is used. If there are three ratings, the median rating is used. If there is one rating, that rating is used. For corporate fixed income securities (given a rating), the probability of default comes from Moody’s annual study of corporate bond defaults published each February. The maximum maturity using the default rate is
The calculation of the credit loss allowance takes the amortized cost of the fixed income security and assumes default and recovery based on the average recovery rates from the Moody’s default studies. The amortized cost of the security, plus any accrued interest, minus the amount recovered, is the estimated full amount the Company could lose in a default scenario. This amount is then multiplied by the probability of default to determine the allowance for credit loss. The lower the security is rated, the higher likelihood of default, and therefore a higher allowance for credit loss. The longer to the maturity date of a security, the higher the default risk.
The table below presents the amortized cost of held-to-maturity securities aggregated by credit quality indicator as of June 30, 2025.
|
|
States and |
|
|
Corporate |
|
|
U.S. Agency |
|
|
U.S. |
|
|
Asset-Backed |
|
|
Totals |
|
||||||
|
|
Amortized Cost |
|
|||||||||||||||||||||
|
|
(in thousands) |
|
|||||||||||||||||||||
AAA/AA/A ratings |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||||
Baa/BBB ratings |
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
||||
Total |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
15
Net realized gains in the quarter ended June 30, 2025 were $
Net realized gains in the six months ended June 30, 2025 were $
During the second quarter of 2025, we recognized through income $
During the six months ended June 30, 2025, we recognized through income $
Investment income is recognized as it is earned. The discount or premium on fixed maturity securities is amortized using the “constant yield” method. Anticipated prepayments, where applicable, are considered when determining the amortization of premiums or discounts. Realized investment gains and losses are determined using the specific identification method.
The Company invests in Exchange Traded Funds with the objective of diversifying portfolio holdings.
Note 5. Income Taxes
In accordance with FASB ASC Topic 740, “Income Taxes,” we provide for the recognition and measurement of deferred income tax benefits based on the likelihood of their realization in future years. As of June 30, 2025 and 2024, we had
Income tax expense from operations is different from the amount computed by applying the U.S. federal income tax statutory rate of
The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. There were
Tax years 2021 through 2024 are subject to examination by the federal and state taxing authorities.
Note 6. Loss Reserves
We record reserves for estimated losses under insurance policies that we write and for loss adjustment expenses related to the investigation and settlement of policy claims. Our reserves for loss and loss adjustment expenses represent the estimated cost of all reported and unreported loss and loss adjustment expenses incurred and unpaid as of a given point in time. The reserves for loss and loss adjustment expenses are estimated using individual case-basis valuations, statistical analyses and estimates based upon experience for unreported claims and their associated loss and loss adjustment expenses. Such estimates may be more or less than the amounts ultimately paid when the claims are settled. The estimates are subject to the effects of trends in loss severity and frequency. Although considerable variability is inherent in these estimates, management believes that the reserves for loss and loss adjustment expenses are adequate. The estimates are continually reviewed internally and periodically evaluated with our independent actuary. Adjustments are made as experience develops and new information becomes known. Any such adjustments are included in income from current operations. See Note 9 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024 for additional information regarding our loss and loss adjustment expense development.
16
The following table provides the Company’s liability for unpaid loss and loss adjustment expenses, net of related amounts recoverable from reinsurers, for the six months ended June 30, 2025 and 2024:
|
|
Six Months Ended June 30, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
|
|
(in thousands) |
|
|||||
Balance, beginning of period |
|
$ |
|
|
$ |
|
||
Less amounts recoverable from reinsurers |
|
|
|
|
|
|
||
Net balance, beginning of period |
|
|
|
|
|
|
||
Add incurred related to: |
|
|
|
|
|
|
||
Current accident year |
|
|
|
|
|
|
||
Prior accident years |
|
|
( |
) |
|
|
( |
) |
Total incurred |
|
|
|
|
|
|
||
Less paid related to: |
|
|
|
|
|
|
||
Current accident year |
|
|
|
|
|
|
||
Prior accident years |
|
|
|
|
|
|
||
Total paid |
|
|
|
|
|
|
||
Net balance, end of period |
|
|
|
|
|
|
||
Add amounts recoverable from reinsurers |
|
|
|
|
|
|
||
Balance, end of period |
|
$ |
|
|
$ |
|
The foregoing reconciliation reflects favorable development of the net reserves at June 30, 2025 and June 30, 2024. The favorable development reduced loss and loss adjustment expenses incurred by $
The table below presents the change in the allowance for credit losses on amounts recoverable from reinsurers for the three and six months ended June 30, 2025 and 2024.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
|
(in thousands) |
|
|
|
|
|
|
|
|||||||
Balance, beginning of period |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Provision for credit loss expense (benefit) |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
|
( |
) |
|
Balance, end of period |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Note 7. Comprehensive Income and Accumulated Other Comprehensive Loss
Comprehensive income includes net income plus unrealized gains and losses on our available-for-sale investment securities, net of tax. In reporting comprehensive income on a net basis in the statements of comprehensive income, we used a
17
The following table illustrates the changes in the balance of each component of accumulated other comprehensive loss for each period presented in the interim financial statements.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Balance, beginning of period |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
Other comprehensive income (loss) before |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
Amounts reclassified from accumulated other |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net current period other comprehensive |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
( |
) |
|
Balance, end of period |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
The sale or credit loss allowance adjustment of an available-for-sale security results in amounts being reclassified from accumulated other comprehensive loss to current period net income.
Component of Accumulated Other |
|
Three Months Ended |
|
|
Six Months Ended |
|
|
Affected line item in the |
||||||||||
Comprehensive Loss |
|
June 30, |
|
|
June 30, |
|
|
statement of income |
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
|
|
||||
|
|
(in thousands) |
|
|
|
|||||||||||||
Unrealized losses on |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
Net realized gains (losses) |
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Income before income taxes |
Unrealized losses on |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
||||
|
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
$ |
( |
) |
|
Net income |
Note 8. Fair Values of Financial Instruments
The Company carries available-for-sale securities and equity securities at fair value in our consolidated financial statements and determines fair value measurements and disclosure in accordance with FASB ASC Topic 820, Fair Value Measurements and Disclosures.
The Company determines the fair values of its financial instruments based on the fair value hierarchy established in ASC Topic 820, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard defines fair value, describes three levels of inputs that may be used to measure fair value, and expands disclosures about fair value measurements.
Fair value is defined in ASC Topic 820 as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is the price to sell an asset or transfer a liability and, therefore, represents an exit price, not an entry price. Fair value is the exit price in the principal market (or, if lacking a principal market, the most advantageous market) in which the reporting entity would transact. Fair value is a market-based measurement, not an entity-specific measurement, and, as such, is determined based on the assumptions that market participants would use in pricing the asset or liability. The exit price objective of a fair value measurement applies regardless of the reporting entity’s intent and/or ability to sell the asset or transfer the liability at the measurement date.
ASC Topic 820 requires the use of valuation techniques that are consistent with the market approach, the income approach and/or the cost approach. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets and liabilities. The income approach uses valuation techniques to convert future amounts, such as cash flows or earnings, to a single present value amount on a discounted basis. The cost approach is based on the amount that currently would be required to replace the service capacity of an asset, also known as current replacement cost. Valuation techniques used to measure fair value are to be consistently applied.
18
In ASC Topic 820, inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk, for example, the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable:
Valuation techniques used to measure fair value are intended to maximize the use of observable inputs and minimize the use of unobservable inputs. ASC Topic 820 establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into the following three levels:
In general, fair value is based upon quoted market prices, where available. If such quoted market prices are not available, fair value is based upon internally developed models that primarily use, as inputs, observable market-based parameters.
The fair values of the Company’s investments are based upon prices provided by an independent pricing service. The Company has reviewed these prices for reasonableness and has not adjusted any prices received from the independent provider. Securities reported at fair value utilizing Level 1 inputs represent assets whose fair value is determined based upon observable unadjusted quoted market prices for identical assets in active markets. Securities reported at fair value using Level 2 inputs represent assets whose fair value is determined using observable market information such as previous day trade prices, quotes from less active markets or quoted prices of securities with similar characteristics. There were no transfers between Level 1 and Level 2 during the six months ended June 30, 2025.
At June 30, 2025, assets measured at fair value on a recurring basis are summarized below:
|
|
June 30, 2025 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Financial instruments carried at fair value, classified as a part of: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Securities available-for-sale—fixed maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
States and political subdivisions |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
||
Corporate bonds |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
U.S. agency-based mortgage-backed securities |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
U.S. Treasury securities |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Total securities available-for-sale—fixed maturity |
|
|
|
|
|
|
|
|
— |
|
|
|
|
|||
Equity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Domestic common stock - Exchange Traded Funds |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
19
At June 30, 2025, assets measured at amortized cost net of allowance for credit losses are summarized below:
|
|
June 30, 2025 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Securities held-to-maturity—fixed maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
States and political subdivisions |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
||
Corporate bonds |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
U.S. agency-based mortgage-backed securities |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
U.S. Treasury securities |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Asset-backed securities |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Total held-to-maturity |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
At December 31, 2024, assets measured at fair value on a recurring basis are summarized below:
|
|
December 31, 2024 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Financial instruments carried at fair value, classified as a part of: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Securities available-for-sale—fixed maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
States and political subdivisions |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
||
Corporate bonds |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
U.S. agency-based mortgage-backed securities |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
U.S. Treasury securities |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Total securities available-for-sale—fixed maturity |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
|||
Equity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Domestic common stock - Exchange Traded Funds |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Total |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
At December 31, 2024, assets measured at amortized cost net of allowance for credit losses are summarized below:
|
|
December 31, 2024 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Securities held-to-maturity—fixed maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
States and political subdivisions |
|
$ |
— |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
||
Corporate bonds |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
U.S. agency-based mortgage-backed securities |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
U.S. Treasury securities |
|
|
|
|
|
— |
|
|
|
— |
|
|
|
|
||
Asset-backed securities |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
||
Total held-to-maturity |
|
$ |
|
|
$ |
|
|
$ |
— |
|
|
$ |
|
The Company determines fair value amounts for financial instruments using available third-party market information. When such information is not available, the Company determines the fair value amounts using appropriate valuation methodologies. Nonfinancial instruments such as real estate, property and equipment, deferred policy acquisition costs, deferred income taxes and loss and loss adjustment expense reserves are excluded from the fair value disclosure.
Cash and Cash Equivalents —The carrying amounts reported in the accompanying consolidated balance sheets for these financial instruments approximate their fair values, which are characterized as Level 1 assets.
Investments —The fair values for fixed maturity and equity securities are based on prices obtained from an independent pricing service. Equity and treasury securities are characterized as Level 1 assets, as their fair values are based on quoted prices in active markets. Fixed maturity securities, other than treasury securities, are characterized as Level 2 assets, as their fair values are determined using observable market inputs.
Short Term Investments —The carrying amounts reported in the accompanying consolidated balance sheets for these financial instruments approximate their fair values. These securities are characterized as Level 2 assets in the fair value hierarchy.
20
The following table summarizes the carrying amounts and corresponding fair values for financial instruments:
|
|
As of June 30, 2025 |
|
|
As of December 31, 2024 |
|
||||||||||
|
|
Carrying |
|
|
Fair |
|
|
Carrying |
|
|
Fair |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Fixed maturity securities—held-to-maturity |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Fixed maturity securities—available-for-sale |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Equity securities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Short-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
Note 9. Treasury Stock
The Company’s Board of Directors (the Board) initiated a share repurchase program in February 2010. In October 2016, the Board reauthorized this program with a limit of $
During the three and six months ended June 30, 2025, the Company repurchased
In July 2025, the Company announced that the Board reauthorized the share repurchase program that replaces the Company's prior program, authorizing the repurchase of shares of the Company's common stock in an aggregate amount of up to $
Note 10. Segment Reporting
The Company operates as a single reportable segment, Insurance Operations, through our wholly-owned subsidiaries. Profits, losses and assets are evaluated on a consolidated basis.
We are a specialty provider of workers’ compensation insurance focused on small to mid-sized employers engaged in high hazard industries. Our Insurance Operations segment derives premium revenues from the sales of workers’ compensation insurance through independent agencies, including retail and wholesale brokers and agents. The accounting policies of the Insurance Operations are the same as those described in the "Summary of Significant Accounting Policies" in Note 1 to our consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2024.
Two of the key financial measures used to evaluate our performance are return on average equity and growth in book value per share. We calculate return on average equity by dividing annual net income by the average of annual shareholders’ equity. We calculate book value per share by dividing ending shareholders’ equity by the number of common shares outstanding.
The measure of segment assets is reported on the balance sheet as total consolidated assets.
The Company does not have intra-entity sales or asset transfers.
The Company is a monoline insurance company operating solely within the U.S. and does
There are no differences from our Annual Report on Form 10-K for the year ended December 31, 2024 in the basis of segmentation or in the basis of measurement of segment profit or loss.
Note 11. Subsequent Events
21
On July 4,2025, the One Big Beautiful Bill Act (OBBBA) was enacted and includes tax reform provisions that amend, eliminate and extend tax rules under the Inflation Reduction Act of 2022 and the Tax Cuts and Jobs Act of 2017 and makes other changes to the Internal revenue Code of 1986, as amended (the Code). While the Company is reviewing the impact of the OBBBA on the Company, the changes to the Code pursuant to the OBBBA are not expected to have a material impact on the Company's results of operations.
On
On July 23, 2025, the Board reauthorized the share repurchase program that replaces the Company's prior program, authorizing the repurchase of shares of the Company's common stock in an aggregate amount of up to $
22
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The financial and business analysis below provides information which the Company believes is relevant to an assessment and understanding of its consolidated financial position, results of operations and cash flows. The following discussion should be read in conjunction with the accompanying unaudited consolidated financial statements and the related notes included in Item 1 of Part I of this Quarterly Report on Form 10-Q, together with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. This discussion includes forward-looking statements that are not guarantees of future performance and are not necessarily indicative of future operating results. See “Forward-Looking Statements” in Part I above for further discussion.
The terms “AMERISAFE,” the “Company,” “we,” “us” or “our” refer to AMERISAFE, Inc. and its consolidated subsidiaries, as the context requires.
Business Overview
AMERISAFE is a holding company that markets and underwrites workers’ compensation insurance through its insurance subsidiaries. Workers’ compensation insurance covers statutorily prescribed benefits that employers are obligated to provide to their employees who are injured in the course and scope of their employment. Our business strategy is focused on providing this coverage to small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. Employers engaged in hazardous industries typically pay substantially higher than average rates for workers’ compensation insurance compared to employers in other industries, as measured per payroll dollar. These higher premium rates are due to the nature of the work performed and the inherent workplace danger of our target employers. Hazardous industry employers also tend to have less frequent but more severe claims as compared to employers in other industries due to the nature of their businesses. We provide proactive safety reviews of most employers’ workplaces. These safety reviews are a vital component of our underwriting process and are aimed at promoting safer workplaces. We utilize intensive claims management practices that we believe permit us to effectively manage the overall cost of our claims. In addition, our audit services ensure that our policyholders pay the appropriate premiums required under the terms of their policies and enable us to monitor payroll patterns that cause underwriting, safety or fraud concerns. We believe that the higher premiums typically paid by our policyholders, together with our disciplined underwriting and safety, claims and audit services, provide us with the opportunity to earn attractive returns for our shareholders.
We actively market our insurance in 27 states through independent agencies (including retail and wholesale brokers and agents), as well as through our wholly owned insurance agency subsidiary. We are also licensed in an additional 20 states, the District of Columbia, and the U.S. Virgin Islands.
Critical Accounting Policies
Understanding our accounting policies is key to understanding our financial statements. Management considers some of these policies to be very important to the presentation of our financial results because they require us to make significant estimates and assumptions. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. Some of the estimates result from judgments that can be subjective and complex and, consequently, actual results in future periods might differ from these estimates.
Management believes that the most critical accounting policies relate to the reporting of reserves for loss and loss adjustment expenses, including losses that have occurred but have not been reported prior to the reporting date, amounts recoverable from reinsurers, premiums receivable, assessments, deferred policy acquisition costs, deferred income taxes, credit losses on investment securities, and share-based compensation. These critical accounting policies are more fully described in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2024. We have not changed any of these policies from those previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.
23
Results of Operations
The following table summarizes our consolidated financial results for the three and six months ended June 30, 2025 and 2024.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
|
(dollars in thousands, except percentages and per share data) |
|
|||||||||||||
|
|
(unaudited) |
|
|||||||||||||
Gross premiums written |
|
$ |
79,704 |
|
|
$ |
76,428 |
|
|
$ |
163,488 |
|
|
$ |
156,502 |
|
Net premiums earned |
|
|
69,381 |
|
|
|
68,633 |
|
|
|
138,266 |
|
|
|
137,079 |
|
Net investment income |
|
|
6,691 |
|
|
|
7,447 |
|
|
|
13,343 |
|
|
|
14,813 |
|
Total revenues |
|
|
81,088 |
|
|
|
75,830 |
|
|
|
153,685 |
|
|
|
156,319 |
|
Total expenses |
|
|
63,633 |
|
|
|
62,086 |
|
|
|
125,009 |
|
|
|
121,830 |
|
Net income |
|
|
13,955 |
|
|
|
10,993 |
|
|
|
22,904 |
|
|
|
27,918 |
|
Diluted earnings per common share |
|
$ |
0.73 |
|
|
$ |
0.57 |
|
|
$ |
1.20 |
|
|
$ |
1.46 |
|
Other Key Measures |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net combined ratio (1) |
|
|
91.7 |
% |
|
|
90.5 |
% |
|
|
90.5 |
% |
|
|
88.8 |
% |
Return on average equity (2) |
|
|
21.2 |
% |
|
|
14.6 |
% |
|
|
17.5 |
% |
|
|
18.8 |
% |
Book value per share (3) |
|
$ |
13.96 |
|
|
$ |
15.78 |
|
|
$ |
13.96 |
|
|
$ |
15.78 |
|
Consolidated Results of Operations for Three Months Ended June 30, 2025 Compared to June 30, 2024
Gross Premiums Written. Gross premiums written for the quarter ended June 30, 2025 were $79.7 million, compared to $76.4 million for the same period in 2024, an increase of 4.3%. The increase was attributable to a $8.5 million increase in voluntary premiums on policies written during the period and a $0.5 million increase in residual market premiums. These increases were partially offset by a $5.8 million decrease in premiums resulting from payroll audits and related premium adjustments for policies written in previous quarters.
Net Premiums Written. Net premiums written for the quarter ended June 30, 2025 were $75.5 million, compared to $72.4 million for the same period in 2024, an increase of 4.3%. The increase was primarily attributable to the increase in gross premiums written. As a percentage of gross premiums earned, ceded premiums were 5.7% for the second quarter of 2025 compared to 5.5% for the second quarter of 2024. The increase in ceded premiums as a percentage of gross premiums earned is a result of a change in our 2025 reinsurance treaties. For additional information, see Item 1, “Business—Reinsurance” in our Annual Report on Form 10-K for the year ended December 31, 2024.
Net Premiums Earned. Net premiums earned for the second quarter of 2025 were $69.4 million, compared to $68.6 million for the same period in 2024, an increase of 1.1%. The increase was primarily attributable to the increase in net premiums written during the period.
24
Net Investment Income. Net investment income for the quarter ended June 30, 2025 was $6.7 million, compared to $7.4 million for the same period in 2024, a decrease of 10.2%. The decrease was due to lower average invested asset balances in the period compared to the same period in the prior year. Average invested assets, including cash and cash equivalents, were $813.1 million in the quarter ended June 30, 2025 compared to an average of $888.7 million for the same period in 2024, a decrease of 8.5%. The pre-tax investment yield on our investment portfolio was 3.3% per annum during each of the quarters ended June 30, 2025 and 2024. The tax-equivalent yield on our investment portfolio was 3.9% per annum for the quarter ended June 30, 2025 compared to 3.8% per annum for the same period in 2024. The tax-equivalent yield is calculated using the effective interest rate and the appropriate marginal tax rate.
Net Realized Gains (Losses) on Investments. Net realized gains on investments for the three months ended June 30, 2025 were $3.1 million compared to net realized losses of $0.1 million for the same period in 2024. Both net realized gains in the second quarter of 2025 and net realized losses in the second quarter of 2024 were mostly attributable to sales of equity and fixed maturity securities classified as available-for-sale.
Net Unrealized Gains (Losses) on Equity Securities. The market value of our equity securities increased by $1.8 million for the three months ended June 30, 2025 compared to a decrease of $0.1 million for the same period in 2024.
Loss and Loss Adjustment Expenses Incurred. Loss and loss adjustment expenses (LAE) incurred totaled $40.7 million for the three months ended June 30, 2025, compared to $40.6 million for the same period in 2024, an increase of $0.1 million, or 0.1%. The current accident year loss and LAE incurred totaled $49.3 million for the three months ended June 30, 2025, compared to $48.7 million for the same period in 2024. As of June 30, 2025, our initial estimate for loss and LAE for accident years 2025 and 2024 remains at 71.0% of net premiums earned, and is based on long-term claim frequency and severity trends, as well as medical inflation. We recorded favorable prior accident year development of $8.6 million in the second quarter of 2025, compared to favorable prior accident year development of $8.1 million in the same period of 2024, as further discussed below in “Prior Year Development.” Our net loss ratio was 58.6% in the second quarter of 2025, compared to 59.2% for the same period of 2024.
Underwriting and Certain Other Operating Costs, Commissions and Salaries and Benefits. Underwriting and certain other operating costs, commissions and salaries and benefits for the quarter ended June 30, 2025 were $21.7 million, compared to $20.4 million for the same period in 2024. This increase was primarily due to a $1.1 million decrease in profit sharing reinsurance commission, a $0.5 million increase in insurance related assessments, a $0.3 million increase in mandatory pooling arrangement fees, and a $0.3 million increase in commission expense. Partially offsetting these amounts was a $0.9 million decrease in professional fees. Our expense ratio was 31.3% in the second quarter of 2025 compared to 29.8% in the second quarter of 2024.
Income Tax Expense. Income tax expense for the three months ended June 30, 2025 was $3.5 million, compared to $2.8 million for the same period in 2024. The effective tax rate for the Company for the quarter ended June 30, 2025 was 20.1% compared to 20.0% in the second quarter of 2024. The increase in the effective tax rate was due to a lower proportion of income from tax-exempt investments for the three months ended June 30, 2025 compared with the same period of 2024.
Consolidated Results of Operations for Six Months Ended June 30, 2025 Compared to June 30, 2024
Gross Premiums Written. Gross premiums written for the six months ended June 30, 2025 were $163.5 million, compared to $156.5 million for the same period in 2024, an increase of 4.5%. The increase was attributable to a $13.7 million increase in voluntary premiums on policies written during the period and a $0.5 million increase in residual market premiums. These increases were partially offset by a $7.1 million decrease in gross premiums written resulting from payroll audits and related premium adjustments for policies written in previous quarters.
Net Premiums Written. Net premiums written for the six months ended June 30, 2025 were $155.1 million, compared to $148.5 million for the same period in 2024, an increase of 4.4%. The increase was primarily attributable to an increase in gross premiums written. As a percentage of gross premiums earned, ceded premiums were 5.7% for the first six months of 2025, compared to 5.5% in the same period of 2024. The increase in ceded premiums as a percentage of gross premiums earned is a result of a change in our 2025 reinsurance treaties. For additional information, see Item 1, “Business—Reinsurance” in our Annual Report on Form 10-K for the year ended December 31, 2024.
Net Premiums Earned. Net premiums earned for the six months ended June 30, 2025 were $138.3 million, compared to $137.1 million for the same period in 2024, an increase of 0.9%. The increase was primarily attributable to the increase in net premiums written during the period.
25
Net Investment Income. Net investment income for the first six months of 2025 was $13.3 million, compared to $14.8 million for the same period in 2024, a decrease of 9.9%. The decrease was due to lower average invested asset balances in the period compared to the same period in the prior year. Average invested assets, including cash and cash equivalents, were $824.1 million in the six months ended June 30, 2025, compared to an average of $895.2 million in the same period in 2024, a decrease of 7.9%. The pre-tax investment yield on our investment portfolio was 3.3% per annum for each of the six months ended June 30, 2025 and 2024. The tax-equivalent yield on our investment portfolio was 3.9% per annum for the first six months of 2025 compared to 3.8% per annum for the same period in 2024. The tax-equivalent yield is calculated using the effective interest rate and the appropriate marginal tax rate.
Net Realized Gains (Losses) on Investments. Net realized gains on investments for the six months ended June 30, 2025 were $3.1 million compared to net realized losses of $0.3 million for the same period in 2024. Both net realized gains in the first six months of 2025 and net realized losses in the first six months of 2024 were mostly attributable to the sales of equity and fixed maturity securities classified as available-for-sale.
Net Unrealized Gains (Losses) on Equity Securities. The market value of our equity securities decreased by $1.3 million for the six months ended June 30, 2025 compared to an increase of $4.7 million for the same period in 2024.
Loss and Loss Adjustment Expenses Incurred. Loss and LAE incurred totaled $80.8 million for the six months ended June 30, 2025, compared to $80.6 million for the same period in 2024, an increase of $0.2 million, or 0.3%. The current accident year loss and LAE incurred totaled $98.2 million for the six months ended June 30, 2025, compared to $97.3 million for the same period in 2024. As of June 30, 2025, our initial estimate for loss and LAE for accident years 2025 and 2024 remains at 71.0% of net premiums earned, and is based on long-term claim frequency and severity trends, as well as medical inflation. We recorded favorable prior accident year development of $17.4 million in the first six months of 2025, compared to favorable prior accident year development of $16.7 million in the same period of 2024, as further discussed below in “Prior Year Development.” Our net loss ratio was 58.5% in the first six months of 2025, compared to 58.8% for the same period of 2024.
Underwriting and Certain Other Operating Costs, Commissions and Salaries and Benefits. Underwriting and certain other operating costs, commissions and salaries and benefits for the six months ended June 30, 2025 were $42.3 million, compared to $39.1 million for the same period in 2024, an increase of 8.2%. This increase was primarily due to an increase in insurance related assessments of $2.6 million, an increase in compensation expense of $0.9 million and an increase in commission expense of $0.5 million. Offsetting these amounts were a decrease in professional fees of $1.0 million and a $0.4 million decrease in taxes and fees. Our expense ratio was 30.6% in the first six months of 2025 compared to 28.5% for the same period of 2024.
Income Tax Expense. Income tax expense for the six months ended June 30, 2025 was $5.8 million, compared to $6.6 million for the same period in 2024. The effective tax rate for the Company increased to 20.1% for the six months ended June 30, 2025 from 19.1% for the six months ended June 30, 2024. The increase in the effective tax rate was due to increased state taxes and the movement of the state deferred tax asset for the six months ended June 30, 2025 compared with the six months ended June 30, 2024.
Liquidity and Capital Resources
Our principal sources of operating funds are premiums, investment income and proceeds from sales and maturities of investments. Our primary uses of operating funds include payments of claims and operating expenses. Currently, we pay claims using cash flow from operations and invest the remaining funds.
Net cash used in operating activities was $10.2 million for the six months ended June 30, 2025, which represented a $15.1 million decrease from $4.9 million in net cash provided by operating activities for the six months ended June 30, 2024. This decrease in operating cash flow was due to a $19.3 million increase in losses paid, a $2.1 million decrease in net investment income and a $1.2 million decrease in reinsurance recoveries. Partially offsetting these impacts were a $4.6 million increase in premium collections, a $1.9 million decrease in underwriting expenses paid, a $0.4 million decrease in dividends paid to policyholders and a $0.4 million decrease in federal taxes paid.
Net cash provided by investing activities was $33.1 million for the six months ended June 30, 2025, compared to net cash provided by investment activities of $5.8 million for the same period in 2024. Cash provided by sales and maturities of investments totaled $54.3 million for the six months ended June 30, 2025, compared to $65.6 million for the same period in 2024. A total of $20.2 million in cash was used to purchase investments in the six months ended June 30, 2025, compared to $59.1 million in purchases for the same period in 2024. A total of $1.1 million in cash was used to purchase property and equipment in the six months ended June 30, 2025, compared to $0.8 million for the same period in 2024.
26
Net cash used in financing activities in the six months ended June 30, 2025 was $18.4 million, compared to net cash used in financing activities of $18.8 million for the same period in 2024. In the six months ended June 30, 2025, $14.9 million of cash was used for dividends paid to shareholders compared to $14.2 million in the same period of 2024. In the six months ended June 30, 2025, there were repurchases of outstanding shares of our common stock of $2.8, million compared to $4.1 million for the same period in 2024. Share-based compensation related payroll tax withholding was $0.7 million in the six months ended June 30, 2025, compared to $0.4 million in the same period in 2024.
Investment Portfolio
The carrying value of our investment portfolio, including cash and cash equivalents, totaled $807.4 million at June 30, 2025, compared to $832.8 million at December 31, 2024, a decrease of 3.1%. Purchases of fixed maturity securities are classified as available-for-sale or held-to-maturity at the time of purchase based on the individual security. The Company has the ability and positive intent to hold certain investments until maturity. Therefore, fixed maturity securities classified as held-to-maturity, as defined by FASB ASC Topic 320, Investments-Debt and Equity Securities, are recorded at amortized cost net of allowance for credit losses. Our equity securities and fixed maturity securities classified as available-for-sale are reported at fair value.
The composition of our investment portfolio, including cash and cash equivalents, as of June 30, 2025, is shown in the following table:
|
|
Carrying |
|
|
Percentage of |
|
||
|
|
(in thousands) |
|
|||||
Fixed maturity securities—held-to-maturity: |
|
|
|
|
|
|
||
States and political subdivisions |
|
$ |
351,880 |
|
|
|
43.6 |
% |
Corporate bonds |
|
|
21,838 |
|
|
|
2.6 |
% |
U.S. agency-based mortgage-backed securities |
|
|
2,573 |
|
|
|
0.3 |
% |
U.S. Treasury securities and obligations of |
|
|
8,522 |
|
|
|
1.1 |
% |
Asset-backed securities |
|
|
9 |
|
|
|
— |
|
Total fixed maturity securities—held-to-maturity |
|
|
384,822 |
|
|
|
47.6 |
% |
Fixed maturity securities—available-for-sale: |
|
|
|
|
|
|
||
States and political subdivisions |
|
|
155,699 |
|
|
|
19.3 |
% |
Corporate bonds |
|
|
132,853 |
|
|
|
16.5 |
% |
U.S. agency-based mortgage-backed securities |
|
|
3,888 |
|
|
|
0.5 |
% |
U.S. Treasury securities and obligations of |
|
|
14,275 |
|
|
|
1.8 |
% |
Total fixed maturity securities—available-for-sale |
|
|
306,715 |
|
|
|
38.1 |
% |
Equity securities |
|
|
52,451 |
|
|
|
6.5 |
% |
Short-term investments |
|
|
14,900 |
|
|
|
1.8 |
% |
Cash and cash equivalents |
|
|
48,465 |
|
|
|
6.0 |
% |
Total investments, including cash and cash equivalents |
|
$ |
807,353 |
|
|
|
100.0 |
% |
Our debt securities classified as available-for-sale are “marked to market” as of the end of each calendar quarter. As of that date, unrealized gains and losses that are not credit related are recorded to accumulated other comprehensive loss. Any available-for-sale credit related losses would be recognized as a credit loss allowance on the balance sheet with a corresponding adjustment to earnings, limited by the amount that the fair value is less than the amortized cost basis. Both the credit loss allowance and adjustment to net income can be reversed if conditions change.
For our debt securities classified as held-to-maturity, non-credit related unrecognized gains and losses are not recorded in the financial statements until realized. Effective upon the adoption of ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses, management is required to estimate held-to-maturity expected credit related losses and recognize a credit loss allowance on the balance sheet with a corresponding adjustment to earnings. Subsequent adjustments to the estimated expected credit related losses are recognized through earnings within the category “provision for investment related credit loss benefit” and adjustments to the credit loss allowance.
27
Prior Year Development
The Company recorded favorable prior accident year development of $8.6 million in the three months ended June 30, 2025. The table below sets forth the favorable development for the three and six months ended June 30, 2025 and 2024 for accident years 2020 through 2024 and, collectively, for all accident years prior to 2020.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
|
(in millions) |
|
|||||||||||||
Accident Year |
|
|
|
|
|
|
|
|
|
|
|
|
||||
2024 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
2023 |
|
|
1.2 |
|
|
|
— |
|
|
|
1.2 |
|
|
|
— |
|
2022 |
|
|
1.5 |
|
|
|
1.3 |
|
|
|
2.4 |
|
|
|
1.3 |
|
2021 |
|
|
0.2 |
|
|
|
1.4 |
|
|
|
3.6 |
|
|
|
1.4 |
|
2020 |
|
|
2.0 |
|
|
|
1.8 |
|
|
|
4.8 |
|
|
|
3.5 |
|
Prior to 2020 |
|
|
3.7 |
|
|
|
3.6 |
|
|
|
5.4 |
|
|
|
10.5 |
|
Total net development |
|
$ |
8.6 |
|
|
$ |
8.1 |
|
|
$ |
17.4 |
|
|
$ |
16.7 |
|
The table below sets forth the number of open claims as of June 30, 2025 and 2024, and the number of claims reported and closed during the three and six months then ended.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
June 30, |
|
|
June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
Open claims at beginning of period |
|
|
3,840 |
|
|
|
3,812 |
|
|
|
3,798 |
|
|
|
4,003 |
|
Claims reported |
|
|
984 |
|
|
|
988 |
|
|
|
1,890 |
|
|
|
1,888 |
|
Claims closed |
|
|
(800 |
) |
|
|
(912 |
) |
|
|
(1,664 |
) |
|
|
(2,003 |
) |
Open claims at end of period |
|
|
4,024 |
|
|
|
3,888 |
|
|
|
4,024 |
|
|
|
3,888 |
|
The number of open claims at June 30, 2025 increased by 136 claims as compared to the number of open claims at June 30, 2024. At June 30, 2025, our incurred amounts for certain accident years, primarily 2017 through 2022, developed more favorably than management previously expected. The revisions to the Company’s reserves reflect new information gained by claims adjusters in the normal course of adjusting claims and is reflected in the Company's financial statements when the information becomes available. It is typical for more serious claims to take several years or longer to settle and the Company continually revises estimates as more information about claimants’ medical conditions and potential disability becomes known and the claims get closer to being settled. Multiple factors can cause both favorable and unfavorable loss development. The favorable loss development we experienced across accident years was largely due to favorable case reserve development from closed claims and claims where the worker had reached maximum medical improvement.
The assumptions we used in establishing our reserves were based on our historical claims data. However, as of June 30, 2025, actual results for certain accident years have been better than our assumptions would have predicted. We do not presently intend to modify our assumptions for establishing reserves in light of recent results. However, if actual results for current and future accident years are consistent with, or different than, our results in these recent accident years, our historical claims data will reflect this change and, over time, will impact the reserves we establish for future claims.
Our reserves for loss and loss adjustment expenses are inherently uncertain and our focus on providing workers’ compensation insurance to employers engaged in hazardous industries generally results in us receiving relatively fewer but more severe claims than many other workers’ compensation insurance companies. As a result of this focus on higher severity, lower frequency business, our reserve for loss and loss adjustment expenses may have greater volatility than other workers’ compensation insurance companies. For additional information, see Item 1, “Business—Loss Reserves” in our Annual Report on Form 10-K for the year ended December 31, 2024.
28
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Market risk is the risk of potential economic loss principally arising from adverse changes in the fair value of financial instruments. The major components of market risk affecting us are credit risk, interest rate risk, and equity price risk. We currently have no exposure to foreign currency risk.
Since December 31, 2024, there have been no material changes in the quantitative or qualitative aspect of our market risk profile. For additional information regarding the Company’s exposure to certain market risks, see Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2024.
Item 4. Controls and Procedures.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act as of the end of the period covered by this report). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report to provide reasonable assurance that information we are required to disclose in reports that are filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms promulgated by the SEC. We note that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving the stated goals under all potential future conditions.
Because of inherent limitations, management does not expect that our disclosure controls and procedures and our internal controls over financial reporting will prevent or detect all misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with policies and procedures may deteriorate. Any control system, no matter how well designed and operated, is based upon certain assumptions and can only provide reasonable, not absolute assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to errors or fraud will not occur or that all control issues and instances of fraud, if any within the Company, have been detected.
There have not been any changes in our internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
29
PART II—OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
As of June 30, 2025, we had repurchased a total of 1,745,608 shares of our outstanding common stock for $44.8 million since inception of our share repurchase program in 2010. The repurchases may be effected from time to time pursuant to trading plans meeting the requirements of Rule 10b5-1 under the Exchange Act. The share repurchase program does not obligate the Company to repurchase any shares of the Company's common stock and may be modified, suspended or terminated at the discretion of the Board. The Board's determination will depend on a variety of factors including, but not limited to, the market conditions and applicable regulatory considerations. It is anticipated that any future repurchases will be funded from available capital.
The following table summarizes the Company’s purchases of its common stock, par value $0.01 per share, during the three months ended June 30, 2025:
Period |
|
Total Number of |
|
|
Average Price Paid |
|
|
Total Number of |
|
|
Approximate Dollar |
|
||||
|
|
|
|
|
|
|
|
|
|
|
(in thousands) |
|
||||
April 1, 2025 to April 30, 2025 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
5,318 |
|
May 1, 2025 to May 31, 2025 |
|
|
131 |
|
|
|
45.47 |
|
|
|
131 |
|
|
|
5,312 |
|
June 1, 2025 to June 30, 2025 |
|
|
62,626 |
|
|
|
44.55 |
|
|
|
62,626 |
|
|
|
2,522 |
|
Total |
|
|
62,757 |
|
|
|
|
|
|
62,757 |
|
|
|
|
(1) Average price paid per share includes commissions and excise tax.
(2) On October 28, 2016, the Company announced that the Board reauthorized the Company’s share repurchase program, authorizing the Company to purchase up to $25.0 million of shares of its outstanding common stock in the aggregate with no expiration date. In July 2025, the Company announced that the Board reauthorized the share repurchase program that replaces the Company's prior program, authorizing the repurchase of shares of the Company's common stock in an aggregate amount of up to $25.0 million with no expiration date. As of July 24, 2025, $25.0 million was available for future repurchases of the Company’s common stock under the repurchase program.
Item 5. Other Information.
During the Company's fiscal quarter ended June 30, 2025, none of the Company's
30
Item 6. Exhibits.
Exhibit No. |
|
Description |
|
|
|
3.1 |
|
Amended and Restated Certificate of Formation of AMERISAFE, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q filed August 6, 2010). |
|
|
|
3.2 |
|
Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed August 6, 2010). |
|
|
|
10.1 |
|
Non-Employee Director Restricted Stock Plan, as amended and restated effective June 6, 2025 (incorporated by reference to Appendix A to the Company’s Proxy Statement on Schedule 14A filed April 30, 2025). |
|
|
|
31.1 |
|
Certification of G. Janelle Frost filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|
|
|
31.2 |
|
Certification of Anastasios Omiridis filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|
|
|
32.1 |
|
Certification of G. Janelle Frost and Anastasios Omiridis filed pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|
|
|
101.INS |
|
XBRL Instance Document – The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document |
|
|
|
101.SCH |
|
Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
|
|
|
104 |
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
|
|
|
31
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
AMERISAFE, INC. |
|
|
|
July 25, 2025 |
|
/s/ G. Janelle Frost |
|
|
G. Janelle Frost |
|
|
President, Chief Executive Officer and Director |
|
|
(Principal Executive Officer) |
|
|
|
July 25, 2025 |
|
/s/ Anastasios Omiridis |
|
|
Anastasios Omiridis |
|
|
Executive Vice President and Chief Financial Officer |
|
|
(Principal Financial and Accounting Officer) |
32